(410 ILCS 416/30)
Sec. 30. Reimbursement status as undue inducement. Reimbursement of ancillary costs incurred by a subject under the program:
(1) does not constitute an undue inducement to participate in a clinical trial; (2) is not considered coercion or the exertion of undue influence to participate in a clinical trial; and (3) shall be deemed to accomplish parity in access to clinical trials and remove barriers to participation in clinical trials for financially burdened subjects. (Source: P.A. 103-227, eff. 6-30-23.)